Recall

Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Recall

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). Product details: Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-412-02

Active Official source

Verification

Official-source record

This page is included in the public index because it is tied to a listed official source. ClaimWatch does not publish trend-only candidates to public SEO pages.

Agency
FDA
Record ID
D-0676-2026
Canonical
https://claimwatch-mvp.vercel.app/item/cipla-usa-inc-cinacalcet-hydrochloride-tablets-90-mg-30-count-bottle-rx-only/

What happened?

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). Product details: Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-412-02

Who may be affected?

USA Nationwide

What should consumers do?

Affected quantity: N/A

Matched search terms

No search trend terms attached yet.

FAQ

Is this page official?

No. ClaimWatch links to official sources and marks whether a page is verified or still being monitored.

Is this legal, medical, or financial advice?

No. This page is informational. Always confirm eligibility, deadlines, and safety instructions through official sources.

Similar alerts